Intracellular domain of the her-2/neu protein for prevention or treatment of malignancies
CA 2216601 C · Owner: University Of Washington · Inventors: Cheever, Martin A.; Disis, Mary L.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Compounds and compositions for eliciting or enhancing immune reactivity to HER- 2/neu protein are disclosed. The compounds include polypeptides and nucleic acid molecules encoding such peptides. The compounds may be used for the prevention or treatment of malignancies in which the HER-2/neu oncogene is associated.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 28, 1996 and granted October 22, 2002. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended March 28, 2016.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 28, 2018.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.